Biotech companies can skyrocket in a short period because of excellent clinical or regulatory progress. And if we take the ...

It has been a rough few months to be invested in homebuilder stocks. This is especially true for Sun Belt-focused builder ...

In the most recent quarter, Realty Income generated $1.05 per share in adjusted funds from operations (AFFO), which are the ...

We recently published a list of 10 Worst Beaten Down Stocks to Buy Now. In this article, we are going to take a look at where ...

Twilio (TWLO) stock’s market-beating rally from early 2024 ended after it published its Q4 earnings on February 13. Despite ...

Political uncertainty, stubborn inflation, and tech sector turbulence have created openings for investors focused on strong ...

Many beaten-down stocks are performing poorly for good reasons. These types of stocks are known as falling knives in the ...

While this was down 1.7% year-over-year, it did beat the forecast by $1.21 million. At the bottom line, UTZ’s non-GAAP quarterly EPS came to 21 cents, beating the forecast by a penny.

These are unquestionably serious issues, but Merck remains a top stock to buy and hold ... with the challenges from ivonescimab and PM8002 down the road.

These are unquestionably serious issues, but Merck remains a top stock to buy and hold, at least for investors focused on the long game. Here's why. Where to invest $1,000 right now? Our analyst ...